Tag: Ad Scientiam
Ad Scientiam Launches International Study to Assess Disability Progression in Multiple...
Ad Scientiam, a global leader in digital biomarkers, has announced a partnership with Sanofi to launch MS-DETECT, an international, multicenter, longitudinal study....
